|Articles|March 1, 2019
- Pharmaceutical Executive-03-01-2019
- Volume 39
- Issue 3
Pharmaceutical Executive, March 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Patient Advocacy: The Corporate Mandatealmost 7 years ago
Patient Support Programs: Cost, Benefit, and Resourcingalmost 7 years ago
Patients is a Virtuealmost 7 years ago
What Does Patient Centricity Look Like?almost 7 years ago
John Crowley: Living the Missionalmost 7 years ago
Research Bonds Strengthenalmost 7 years ago
Parallel Trade a Victim of Brexit Collateral Damagealmost 7 years ago
Multiple Pharma Issues Top Congressional Agendaalmost 7 years ago
Pharm Exec Joins MJH Portfolioalmost 7 years ago
Cystic Fibrosis: The Importance of Patient AdvocacyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5